Search Results

You are looking at 71 - 80 of 372 items for :

  • "therapeutics" x
  • Refine by Access: All x
Clear All
Full access

NCCN: The Future is Bright

Samuel M. Silver

revolution, and the experts on our Guideline Panels are the ideal physician-scientists to offer ever-changing guidance in this exciting new world of oncology therapeutics. It has been my pleasure to serve as Chair of the Board of NCCN for these past few

Full access

Put Us Out of Business—Please!

Margaret Tempero

for which there is no sponsor. The infrastructure exists and has been used for prevention studies, although not many. Why not expand the capability there and shift the focus of the NCTN away from therapeutics and into prevention? This would give this

Full access

NCCN Evolving Through the Decades: A Continuum of Commitment and Mission

Al B. Benson III

further enhanced its educational and informational programs consistent with its mission to improve the safety, effectiveness, and efficiency of cancer care. A variety of symposia were introduced, including Innovative Diagnostics & Therapeutics in Cancer

Full access

Summary and Comparison of Myeloid Growth Factor Guidelines in Patients Receiving Cancer Chemotherapy

Gary H. Lyman and Jessica Malone Kleiner

. 18. Lyman GH Kuderer NM . Economics of hematopoietic growth factors . In: Morstyn G, Foote M, Lieschke GJ, eds. Cancer Drug Discovery and Development . Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics

Full access

Dying in the Queue and Where Is My Nurse?

Margaret Tempero

therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer Cancer Foundation Board. She codirected the AACR/ASCO Methods in Clinical Cancer Research and taught this course and similar

Full access

I’m Getting Better at This!

Margaret Tempero

pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer Cancer Foundation Board. She codirected the AACR

Full access

Tackling Cost: A Prescription for Spending Wisely

Margaret Tempero

investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer Cancer Foundation Board. She codirected the AACR/ASCO Methods in Clinical Cancer Research and taught this course and

Full access

Something to Crow About!

Margaret Tempero

Director of the UCSF Pancreas Center and editor-in-chief of JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as

Full access

Taking Our Hands Off the Wheel

Margaret Tempero

Margaret Tempero, MD, is a Professor of Medicine and Director of the UCSF Pancreas Center and editor-in-chief of JNCCN . Her research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. Dr

Full access

Clinical Trials: Does One Size Really Fit All?

Margaret Tempero

adenocarcinoma, especially in the area of investigational therapeutics. Dr. Tempero has served on the ASCO Board of Directors and as ASCO President. She currently serves on the ASCO Conquer Cancer Foundation Board. She codirected the AACR/ASCO Methods in Clinical